Aliqopa (copanlisib) | Friends of Cancer Research

You are here

Aliqopa (copanlisib)

Sponsor: 
Bayer
Indication: 
Adults patients with relapsed marginal zone lymphoma (MZL) who have received at least 2 prior therapies
Category: 
Year: 
2019
Date: 
May 30th
FDA Status: 
Designation Granted